Tarlatamab (1) – Imdylltra®
Advanced small-cell lung cancer, previously treated
Characteristics
| Start date | 01.07.2026 |
|---|---|
| Resolution | 17.12.2026 – active procedure |
| INN | Tarlatamab |
| Brand name | Imdylltra® |
| Pharm. company | Amgen GmbH |
| G-BA Procedure ID | D-1340 |
| Therapeutic area | Oncological diseases Orphan |
| Reason for procedure | Initial assessment |
Associated procedures
| Tarlatamab (1) | Imdylltra® | Amgen GmbH | Advanced small-cell lung cancer, previously treated | n.d. | active procedure Orphan |
<< List of all resolutions